Tiens (301263.SZ) announced that its wholly-owned subsidiary Jiangsu Bochuangyuan Biomedical Technology Co., Ltd. (referred to as Bochuangyuan)
Wisdom Financial APP News, Tiens (301263.SZ) announced that its wholly-owned subsidiary Jiangsu Bochuangyuan Biomedical Technology Co., Ltd. (referred to as Bochuangyuan) has organized the completion of all subjects in II phase clinical trial of innovative drug CKBA cream for the treatment of vitiligo indications according to the clinical trial plan.